This guideline presents recommendations for the management of patients with hereditary
gastrointestinal cancer syndromes. The initial assessment is the collection of a family history …

Colorectal cancer (CRC) is the fourth most common cancer amongst men and women.
Between 3 and 6% of all CRCs are attributed to well-defined inherited syndromes, including …

ESGE recommends that individuals with hereditary gastrointestinal polyposis syndromes
should be surveilled in dedicated units that provide monitoring of compliance and …

Considerable evidence supports the effectiveness of aspirin for chemoprevention of
colorectal cancer (CRC) in addition to its well-established benefits in the prevention of …

Importance Patients with familial adenomatous polyposis (FAP) are at markedly increased
risk for duodenal polyps and cancer. Surgical and endoscopic management of duodenal …

Colorectal cancer (CRC) is a major cause of morbidity and mortality in the world. Up to 30%
of CRCs have evidence of a familial component, and about 5% are thought to be due to well …

Familial adenomatous polyposis (FAP) is a well-described inherited syndrome,
characterized by the development of hundreds to thousands of adenomas in the colorectum …

Abstract Background The British Society of Gastroenterology recommends that all familial
adenomatous polyposis (FAP) and Lynch syndrome (LS) families are screened in the …

Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) is a recently
described, rare gastric polyposis syndrome. It is characterized by extensive involvement of …

Familial adenomatous polyposis (FAP) syndrome is a complex entity, which includes FAP,
attenuated FAP, and MUTYH-associated polyposis. These patients are at significant risk for …